Long-Term Safety and Efficacy of Tocilizumab in Early Systemic Sclerosis-Interstitial Lung Disease: Open-Label Extension of a Phase 3 Randomized Controlled Trial.
Khanna D, Lin CJF, Furst DE, Wagner B, Zucchetto M, Raghu G, Martinez FJ, Goldin J, Siegel J, Denton CP.
Am J Respir Crit Care Med. 2022 Mar 15;205(6):674-684. doi: 10.1164/rccm.202103-0714OC.
PMID:34851799
Pulmonary sclerosis.
JERVELL O.
Acta Med Scand. 1950;138(6):430-6. doi: 10.1111/j.0954-6820.1950.tb10141.x.
PMID:14789480
Advances in the identification and management of progressive pulmonary fibrosis: perspective from Chinese experts.